U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012538) titled 'RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer' on May 30.
Brief Summary: The goal of this retrospective cohort study is to learn about the long-term effects of renin-angiotensin system inhibitors (RASi) in preventing patients with hypertension and stage II/III colon cancer from recurrence and metastases after radical resection. The main question it aims to answer is:
Does RASi improve the 3-year disease-free survival of patients with hypertension and stage II/III colon cancer after surgery? Participants with hypertension and already having radical resection of stage II/III colon cancer will be followed u...